Compare Home Depot Inc (HD) vs Invesco Ltd. (IVZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs Invesco Ltd. — how do they compare? Home Depot Inc trades at $347.36 (market cap $353.46B), while Invesco Ltd. trades at $31.46 (market cap $13.85B). The key difference: Home Depot Inc is far larger — about 25.5× Invesco Ltd.'s market cap, and Invesco Ltd. pays the higher dividend (2.74%). Which is the better fit depends on your goals.
| HD | IVZ | |
|---|---|---|
Market Cap | $353.46B | $13.85B |
Sector | Consumer Cyclical | Financials |
52-Week High | $423.42 | $32.01 |
52-Week Low | $297.51 | $20.67 |
Enterprise Value | $415.01B | $24.01B |
Dividend Yield | 2.63% | 2.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $347.22, down 1.01% today, with a bullish technical signal from moving averages but overbought RSI readings. Revenue grew to $159.51 billion in 2025, though net income margin declined to 8.41%. Recent earnings show mixed results, with a Q2 2026 EPS estimate of $4.73. Analyst consensus is bullish with a $371.25 price target, supported by institutional activity and a $2.33 dividend payment scheduled for June 2026.
The stock offers long-term value with strong profitability (ROE 128.38%) and analyst optimism, but faces risks from weakening housing demand and margin pressure. Upside potential exists if Pro business growth offsets macroeconomic headwinds, though high valuation multiples (P/E 25.18) warrant caution amid rising interest rates.
Invesco (IVZ) trades at $31.74, near its 52-week high, with a bullish technical signal supported by moving averages. The company reported mixed quarterly earnings but maintains strong operating cash flow of $1.53 billion for 2025. Recent news highlights record assets under management and positive analyst coverage, though profitability metrics show net income margin at -0.93%.
The outlook remains cautiously optimistic with a consensus price target of $32.50, offering modest upside. Key risks include volatile earnings and expense pressures, while institutional interest and dividend payments provide support. Investors should weigh solid cash generation against margin challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →
